1. The interleukin 2 secretion defect in vitro in systemic lupus erythematosus is reversible in rested cultured T cells;P, Huang Y.; A, Miescher P.; H, Zubler R.;J Immunol,1986
2. Characterization of T lymphocyte subpopulations responsible for deficient interleukin 2 activity in patients with systemic lupus erythematosus;Murakawa, Y.; Takada, S.; Ueda, Y.; Suzuki, N.; Hoshino, T.; Sakane, T.;J Immunol,1985
3. Defective monocyte production of, and T lymphocyte response to, IL-I in the peripheral blood of patients with systemic lupus erythematosus. Clin Exp Immunol;Alcocer-Varela, J.; Laffon, A.; Alarcon-Segocia, D.,1983
4. The in vitro production and regulation of anti-dsDNA antibodies by PBMNCs from normals and patients with SLE. Clin Exp Immunol;S, Mach P.; M, Kharouby; F, Lutcher,1984
5. Suppressor cell function defect in idiopathic SLE;S, Krakauer R.; D, Clough J.; S, Krank; J, Sundeen;Clin Immunol Immunopathol,1979